New York Professional Events List


2nd Strategic Partnerships for Drug Repurposing Forum


Date
Oct 26, 2017 - 08:00 AM
Organizer
ExL Events
Venue
Hyatt Regency Boston Harbor
Location
101, Harborside Dr

Boston,
MA,
USA,
ZIP: 02128
Phone:

Drug repurposing, repositioning, and rescue all allow pharmaceutical companies to maintain or increase the lifecycle of drugs and decrease the expense of the full research and development process. In today’s society, life science organizations not only develop strategies and methods to help find cures for diseases; they also utilize data from past clinical trials to uncover potential new indications to repurpose, reposition or rescue a drug. With more than 7,000 known diseases worldwide, drug repurposing provides an alternative route for companies to provide treatments to patients faster.

At ExL’s 2nd Strategic Partnership for Drug Repurposing Forum you will hear the latest indications for repurposing, rescuing and repositioning existing drugs to explore the newest innovations. Attendees will learn about the different resources available to them, including public-private partnerships, foundations, patient advocacy groups, universities and other funding partners. Come network and build partnerships with all stakeholders.

 Top Five Reasons to Attend

  1. Engage in case studies and panel discussions on how to excel in searching for drug repurposing opportunities and uncover new indications for existing drugs
  2. Cover new methods in the pipeline by using innovative strategies to discover new therapeutic uses for existing molecules
  3. Identify new technologies used for the evaluation of repurposed drugs
  4. Explore how to develop strategic partnerships between the government, universities, patient advocacy groups, foundations, and sponsors
  5. Understand the FDA regulations (505b) for New Drug Applications, the legal framework and intellectual property laws surrounding drug repurposing

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology and medical device organizations; patient organizations; and nonprofit foundations with responsibilities in the following areas:

  • Drug Repurposing
  • Indication Expansion
  • Strategic Partnerships and Alliances
  • Global Commercialization/Strategy
  • Program and Portfolio Development
  • Translational Medicine
  • Strategy and Portfolio Solutions
  • Corporate Strategy
  • Market Access
  • Asset Management
  • Advanced Brand Strategies
  • Research and Development
  • Scientific/Clinical Development
  • Regulatory Affairs
  • Bioinformatics
  • Big Data Analytics
  • Patient Networks

This event is also of interest to professionals involved in:

  • Clinical Operations/Clinical Outsourcing
  • Trauma Therapeutics
  • Drug Delivery/Discovery
  • Product Development
  • Clinical Operations

Day One

 Thursday, October 26, 2017

8:00AM – 8:45AM

Registration and Continental Breakfast

 
 

 

8:45AM – 9:00AM

Co-Chairpersons’ Opening Remarks

 
 

Bruce Bloom, President and Chief Science Officer, CURES WITHIN REACH
Craig Wegner, Executive Director, Boston Head, Emerging Innovations, Scientific Partnering and Alliances, ASTRAZENECA PHARMACEUTICALS

9:00AM – 9:45AM

Big Data and Drug Repositioning: Made for Each Other

 
 

Aris Persidis, President, BIOVISTA

9:45AM – 10:30AM

CASE STUDY: Clinical Validation Successes Have Now Emerged From Strategic Open Innovation Partnerships – Is This Now a Certified Path for Drug Repositioning

 
 

Craig Wegner, Executive Director, Boston Head, Emerging Innovations, Scientific Partnering and Alliances, ASTRAZENECA

10:30AM – 11:00AM

Networking Break

 
 

 

11:00AM – 11:45AM

PANEL: Partnerships With Sponsors, Patient Advocacy, Government and Research of Drug Developments

 
 

Brian Fisher, Vice President of Operations and Corporate Partnerships, STURGE-WEBER FOUNDATION
Bobbie Austin, Program Officer, Drug Development Partnership Programs, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NIH
Chitra Edwin, RAC Senior Vice President of Regulatory Affairs and Compliance, SPOTLIGHT INNOVATION
Sean Evans, Director, Planning and Market Analysis, Johns Hopkins Medicine

12:30PM – 1:30PM

Networking Lunch

 
 

 

1:30PM – 2:15PM

Recycling the Recycling Model: Building Economic Incentives Into Generic Drug Repurposing

 
 

Bruce Bloom, President and Chief Science Officer, CURES WITHIN REACH

2:15PM – 3:00PM

Panel: Two Case Studies on Computational Strategies for Drug Repurposing

 
 

Moderator:
Bobbie Austin, Program Officer, Drug Development Partnership Programs, NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES, NIH

Panelists:
David M. Aronoff, Director, Division of Infectious Diseases, Addison B. Scoville Jr. Chair in Medicine, Professor of Medicine, VANDERBILT UNIVERSITY
Bin Chen, Assistant Professor, Dept. of Pediatrics and Institute for Computational Health Sciences, UCSF

3:00PM – 3:45PM

Pharma Experiences and Challenges in Evolving New Technologies for Repurposing Drugs

 
 

Pankaj Agarwal, GSK Senior Fellow, Computational Biology, GLAXOSMITHKLINE

3:45PM – 4:15PM

Networking Break

 
 

 

4:15PM – 5:00PM

Phenotypic Screening and Machine Learning: A Powerful Combination for Future Drug Discovery and Repurposing

 
 

Hassan Al-Ali, Ph.D., Research Assistant Professor, UNIVERSITY OF MIAMI; Chief Scientific Officer, TRUVITECH LLC

5:00PM – 5:45PM

Integrative Technology Platform to Speed Up the Process of Drug Repurposing

 
 

Stephen Wong, Chairman and Professor, Department of Systems Medicine and Bioengineering, and Chief Research Information Officer, HOUSTON METHODIST HOSPITAL

5:45PM – 5:45PM

End of Main Conference Day One

Day Two

 Friday, October 27, 2017

8:00AM – 8:30AM

Continental Breakfast

 
 

 

8:30AM – 8:45AM

Co-Chairpersons’ Recap of Day One

 
 

Bruce Bloom, President and Chief Science Officer, CURES WITHIN REACH
Craig Wegner, Executive Director, Boston Head, Emerging Innovations, Scientific Partnering and Alliances, ASTRAZENECA PHARMACEUTICALS

8:45AM – 9:30AM

Predict the Safety and Efficacy of Small Molecules Using Deep Learning Techniques

 
 

Alex Aliper, President of European Operations, INSILICO MEDICINE

9:30AM – 10:15AM

Drug Repurposing for Rare Diseases at National Center of Toxicological Research

 
 

Zhichao Liu, Staff Fellow, NCTR, FDA

10:15AM – 11:00AM

A Pharma Approach to Industrializing Methodologies for Identification of Robust Drug Repurposing Candidates

 
 

Daphna Laifenfeld, Senior Director, Personalized and Predictive Medicine, TEVA

11:00AM – 11:30AM

Networking Break

 
 

 

11:30AM – 12:15PM

PANEL: How to Evaluate the Pricing and Value of a Repurposed Drug

 
 

Antoun Nabhan, Chief Financial Officer, ESTABLISHMENT LABS

12:15PM – 1:00PM

CASE STUDY: Engaging the Patient Community in Repurposed Drug Trials

 
 

Bernadette Siddiqi, Research Programs Officer, THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH

1:00PM – 2:00PM

Luncheon

 
 

 

2:00PM – 2:45PM

CASE STUDY: The Development of a New Molecule of an Old Drug in a New Orphan Disease

 
 

Raymond K. Houck, President and Chief Executive Officer, THAR PHARMACEUTICALS

2:45PM – 3:15PM

CASE STUDY: Explore Development Paths and Challenges in Drug Repurposing

 
 

Neal Farber, Chief Executive Officer, NEUROHEALING PHARMACEUTICALS

3:15PM – 3:45PM

Networking Break

 
 

 

3:45PM – 4:15PM

A KnowledgeBase to Aggregate and Prioritize Data on Generic Drug Repurposing for Cancer

 
 

Laura Kleiman, Executive Director, CURES WITHIN REACH FOR CANCER

4:15PM – 4:15PM

Conference Concludes




 

Event Categories
BUSINESS & MANAGEMENT CONFERENCES
Keywords: fun, analysis, access , applications, biology , Clinical , community , conference , design , development




Comments








Events Calendar

SunMonTueWedThuFriSat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99